To investigate whether exogenously introduced EV-TβRII could suppress the anti-tumor immune response and promote tumor growth, we transplanted 4T1 cells in mice followed by tail vein injections of in vitro collected TEVs from either their WT or TβRII null counterparts (Fig. 6k). The gene discussed is TGFBR2; the disease is neoplasm.